These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30251273)

  • 1. Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis.
    Shi SY; Chen KL; Gu J; Xu C; Chen QR; Chen YQ; Xu T; Ke HY; Sun JH; Ye F
    J Interv Cardiol; 2018 Dec; 31(6):737-746. PubMed ID: 30251273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.
    Hou J; Jia H; Liu H; Han Z; Yang S; Xu C; Schmitt J; Zhang S; Yu B; Jang IK
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1879-86. PubMed ID: 22422037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
    Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
    Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vessel curvature on neointimal healing after stent implantation as assessed by optical coherence tomography.
    Fu Y; Zhang S; Du H; Li L; Wang C; Zheng G; Wang Y; Dong H; Jia H; Yu B
    Medicine (Baltimore); 2018 Apr; 97(16):e0518. PubMed ID: 29668639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis.
    Lee SY; Hong MK; Mintz GS; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Int J Cardiovasc Imaging; 2014 Aug; 30(6):1003-11. PubMed ID: 24807243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and quantitative analysis of vascular wall and neointimal hyperplasia after coronary stenting: comparison of bare-metal and sirolimus-eluting stents using optical coherence tomography.
    Goto I; Itoh T; Kimura T; Fusazaki T; Matsui H; Sugawara S; Komuro K; Nakamura M
    Circ J; 2011; 75(7):1633-40. PubMed ID: 21628836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 9. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.
    Jang JY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2015 Oct; 242(2):553-9. PubMed ID: 26318104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
    Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.
    Kwon SW; Kim BK; Kim TH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2011 Feb; 161(2):367-72. PubMed ID: 21315221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry.
    Kobayashi T; Sotomi Y; Suzuki S; Hamanaka Y; Nakatani S; Dijkstra J; Onuma Y; Serruys PW; Sakata Y; Hirayama A; Higuchi Y
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):205-215. PubMed ID: 31673850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference of vascular healing between bioabsorbable-polymer and durable-polymer new generation drug-eluting stents: an optical coherence tomographic analysis.
    Matsuhiro Y; Nakamura D; Shutta R; Kawamura A; Nakamura H; Okamoto N; Matsunaga-Lee Y; Yano M; Egami Y; Sakata Y; Nishino M; Tanouchi J
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1131-1141. PubMed ID: 33165669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography.
    Yonetsu T; Kim JS; Kato K; Kim SJ; Xing L; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Uemura S; Yu B; Kakuta T; Jang IK
    Am J Cardiol; 2012 Oct; 110(7):933-9. PubMed ID: 22727183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
    Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
    Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.